首页> 外文OA文献 >Effect of Pressure-Heat Sealing Used in Making Discrete Powder Preparations of Live Lactic Acid Bacteria
【2h】

Effect of Pressure-Heat Sealing Used in Making Discrete Powder Preparations of Live Lactic Acid Bacteria

机译:加压热封法在制备乳酸菌离散粉剂中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

We investigated the numbers of live bacteria in the lactic acid bacteria containing powder products Lac-B? granular powder (Bifidobacterium ),Lebenin? (Antibiotics-resistant lactic acid bacteria),and Biolactis? powder (Lactobacillus casei ) before and after applying the pressure-heat sealing used in making discrete preparations of these products.The numbers of live lactic bacteria in all preparations were significantly reduced by pressure-heat sealing with a drop to 1/4 of that stated in the package insert for Lac-B? granular powder.In the case of Lebenin? and Biolactis? powder,the bacteria numbers dropped to 1/10 and 1/70 of those stated,respectively.It is thus unlikely that the number of live bacteria stated in the package inserts would be achieved for these products and one could not expect the clinical effects of the bacteria to be fully manifested when discrete preparations of the latter two products were orally administered. In order to clarify whether the numbers of live lactic acid bacteria were reduced by heat-treatment during the sealing of the package,all products were maintained at 115°C for 5 seconds in a thermostat.The results were almost identical to those obtained for pressure-heat sealing,suggesting that the decreases in numbers of the live bacteria in discrete preparations was mainly due to the heat-treatment involved in pressure-heat sealing. In conclusion,we propose that when making discrete preparations of lactic acid bacteria products,in particular Lebenin? and Biolactis? powder,no heating should be used in the sealing process.
机译:我们调查了含有粉状产品Lac-B?的乳酸菌中活细菌的数量。粒状粉末(双歧杆菌),Lebenin? (抗抗生素乳酸菌)和Biolactis?粉末和干酪粉(干酪乳杆菌)在使用这些产品的离散制剂之前和之后进行加压热封。加压热封显着减少了所有制剂中活乳酸菌的数量,降至所述数量的1/4在Lac-B的包装说明书中?粒状粉末。和Biolactis?粉末,细菌数量分别下降到所述数量的1/10和1/70。因此,这些产品的包装插页中所述的活细菌数量不太可能达到,并且人们不能期望当口服后两种产品的不连续制剂时,细菌将完全表现出来。为了弄清楚在包装密封过程中是否通过热处理减少了活乳酸菌的数量,所有产品均在恒温器中于115°C保持5秒钟,结果与加压获得的结果几乎相同热密封,这表明不连续制剂中活菌数量的减少主要是由于压力热密封所涉及的热处理。总之,我们建议在制备乳酸菌产品(尤其是Lebenin)的离散制剂时?和Biolactis?粉末,在密封过程中不得使用加热。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号